Table 3.
Target for tuberculin skin testing and who should be considered for treatment.
| Tuberculin skin test reaction size, (mm induration) | Situation in which reaction is considered positive |
|---|---|
| TST≥5 mm | HIV seropositive |
| Close contact with positive AFB in the sputum | |
| Fibrotic changes on chest radiograph consistent with prior untreated tuberculosis | |
| Organ transplants and other immunosuppressed patients (e.g., persons receiving the equivalent of 15 mg/day of prednisone for at least 30 days or more) | |
| TST≥10 mm | Injection drug use |
| Residents and employees in high-risk settings: nursing homes, and other long-term care facilities, hospitals | |
| Persons at increased risk of developing active tuberculosis: those with silicosis, diabetes mellitus, chronic renal failure, leukemia, lymphoma, cancer of the head, neck or lung, weight loss of more than 10% of ideal body weight, gastrectomy, jejunoileal bypass | |
| Children younger than four years of age | |
| TST≥15 mm | Persons with no risk factors for tuberculosis |
| Contraindications for treatment | Any clinical, radiological, or bacteriological evidence of TB disease |